bioRxiv is receiving many new papers on coronavirus SARS-CoV-2.   A reminder: these are preliminary reports that have not been peer-reviewed. They should not be regarded as conclusive, guide clinical practice/health-related behavior, or be reported in news media as established information.

COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

12,492 Articles (9,715 medRxiv, 2,777 bioRxiv)

Most recent first Previous |  Page 8: Articles 71-80  | Next

The Role of Disease Severity and Demographics in the Clinical Course of COVID-19 Patients Treated with Convalescent Plasma
Ma, T., Wiggins, C. C., Kornatowski, B. M., Hailat, R. S., Clayburn, A. C., Guo, W., Johnson, P. W., Senefeld, J. W., Klassen, S. A., Baker, S. E., Bruno, K. A., Fairweather, D., Wright, R. S., Carter, R. E., Li, C., Joyner, M. J., Paneth, N.
10.1101/2021.01.19.21249678 — Posted: 2021-01-20
Clinical utility of Corona Virus Disease-19 serum IgG, IgM, and neutralizing antibodies and inflammatory markers
Schaefer, E. J., Comite, F., Dulipsingh, L., Lang, M., Jimison, J., Grajower, M. M., Lebowitz, N. E., Geller, A. S., Diffenderfer, M. R., He, L., Breton, G., Dansinger, M. L., Saida, B., Yuan, C.
10.1101/2021.01.19.21249604 — Posted: 2021-01-20
Emergence of a novel SARS-CoV-2 strain in Southern California, USA
Zhang, W., Davis, B., Chen, S. S., Sincuir Martinez, J., Plummer, J. T., Vail, E.
10.1101/2021.01.18.21249786 — Posted: 2021-01-20
City Reduced Probability of Infection (CityRPI) for Indoor Airborne Transmission of SARS-CoV-2 and Urban Building Energy Impacts
Katal, A., Albettar, M., Wang, L.
10.1101/2021.01.19.21250046 — Posted: 2021-01-20
Issues of Random Sampling with Rapid Antigen Tests for COVID-19 Diagnosis: A Special Reference to Kalmunai RDHS Division
Mohamed, R. A., Junaideen, S. M.
10.1101/2021.01.11.21249636 — Posted: 2021-01-20
Optimizing SARS-CoV-2 vaccination strategies in France: Results from a stochastic agent-based model
Hoertel, N., Blachier, M., Limosin, F., Sanchez-Rico, M., Blanco, C., Olfson, M., Luchini, S., Schwarzinger, M., Leleu, H.
10.1101/2021.01.17.21249970 — Posted: 2021-01-20
Hidden Parameters impacting resurgence of SARS-CoV-2 Pandemic
Zhang, Y., Kapoor, S.
10.1101/2021.01.15.20248217 — Posted: 2021-01-20
Impact of Public Health Education Program on the Novel Coronavirus Outbreak in the United States
Iboi, E. A., Richardson, A., Ruffin, R., Ingram, D., Clark, J., Hawkins, J., McKinney, M., Horne, N., Ponder, R., Denton, Z., Oduro, B., Akinyemi, L.
10.1101/2021.01.18.21250047 — Posted: 2021-01-20
State-of-the-Art Risk Models for Diabetes, Hypertension, Visual Diminution, and COVID-19 Severity in Mexico
Amaya, H., Enciso, J., Meizner, D., Pentland, A., Noriega, A.
10.1101/2021.01.18.21250034 — Posted: 2021-01-20
Analysis of communities of countries with similar dynamics of the COVID-19 pandemic evolution
Alvarez, E., Brida, J. G., Limas, E., Rosich, L.
10.1101/2021.01.18.21250050 — Posted: 2021-01-20

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).